Reassessing the Risk of Esophageal Cancer in Achalasia Post‐Therapy: Findings From a Large United States Multi‐Centre Retrospective Propensity‐Matched Cohort Study
The elevated cancer risk in achalasia over a short follow-up period warrants reconsideration of current endoscopic surveillance guidelines, despite the low absolute risk of esophageal cancer and BE.
Authors
- Varan Perananthan (ORCID: https://orcid.org/0000-0002-4087-4998)
- Azizullah Beran (ORCID: https://orcid.org/0000-0002-4161-942X)
- M Mohammed (ORCID: https://orcid.org/0000-0002-2690-0790)
- Jeffrey A. Alexander (ORCID: https://orcid.org/0000-0003-0872-7936)
- Karthik Ravi (ORCID: https://orcid.org/0000-0001-9863-7736)
- Don C. Codipilly (ORCID: https://orcid.org/0000-0003-3197-0539)
- Marcelo F. Vela (ORCID: https://orcid.org/0000-0002-5350-4654)
- Cadman L. Leggett (ORCID: https://orcid.org/0000-0002-0495-3795)
- Diana L. Snyder (ORCID: https://orcid.org/0000-0002-4923-3978)
- Osama Hamid (ORCID: https://orcid.org/0000-0002-2426-1251)
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Indiana University – Purdue University Indianapolis (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Neurogastroenterology & Motility
- Published
- 2025-08-31
- DOI
- https://doi.org/10.1111/nmo.70151
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00